Delivery Order SPE2DB24D2018-SPE2DB25FWWV1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Briviact 100 mg tablets (60-count packages) with a ceiling value of $1,067.55. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Briviact 100 mg tablets (60 count) under a firm fixed-price contract valued at $2,794.07. This non-set-aside award represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,861.34 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Briviact 25 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $3,639.16. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. The award was competitively granted with no set-aside designation...
- The Defense Logistics Agency awarded a $5,572.14 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Briviact 100 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,166.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be performed and...
- The Defense Logistics Agency awarded a delivery order valued at $7,488.40 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Briviact 100 mg tablets (60-count unit) under a firm fixed-price contract valued at $1,498.21. This is a non-set-aside competitive award with a completion date of May 2, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,165.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Briviact 100 mg tablets (60-count units). This is a non-set-aside, competitively awarded delivery order with performance in Conshohocken, Pennsylvania, scheduled for completion by June 20, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWV1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Briviact 25 mg tablets in a quantity of 60 units, with a ceiling value of $3,121.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement valued through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement and military healthcare systems. The company's DLA prime vendor contract enables it to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Briviact, an antiepileptic medication, exemplifies the routine pharmaceutical fulfillment operations conducted under the company's expansive federal contract vehicle to support military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/17/25 |